摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(4-吗啉羰基)苯硼酸频那醇酯 | 1036991-25-9

中文名称
3-(4-吗啉羰基)苯硼酸频那醇酯
中文别名
3-(4-吗啉基羰基)苯基硼酸频哪醇酯
英文名称
morpholino(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone
英文别名
morpholin-4-yl-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanone
3-(4-吗啉羰基)苯硼酸频那醇酯化学式
CAS
1036991-25-9
化学式
C17H24BNO4
mdl
——
分子量
317.193
InChiKey
PKONGXZPUDFPPH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    78-84 °C
  • 沸点:
    478.7±40.0 °C(Predicted)
  • 密度:
    1.14±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.46
  • 重原子数:
    23
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.59
  • 拓扑面积:
    48
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2934999090
  • 危险性防范说明:
    P261,P264,P271,P280,P302+P352,P304+P340,P305+P351+P338,P312,P362,P403+P233,P501,P330,P361,P363,P391,P403+P233,P405,P501
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    室温

SDS

SDS:3476f6695aa2d39021f057753b5f4295
查看
Material Safety Data Sheet

Section 1. Identification of the substance
3-(4-Morpholinylcarbonyl)phenylboronic acid pinacol ester
Product Name:
Synonyms: 3-(4-Morpholinylcarbonyl)phenylboronic acid pinacol ester

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

Section 3. Composition/information on ingredients.
3-(4-Morpholinylcarbonyl)phenylboronic acid pinacol ester
Ingredient name:
CAS number: 1036991-25-9

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C17H24BNO4
Molecular weight: 317.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Identification of new γ-hydroxybutenolides that preferentially inhibit the activity of mPGES-1
    摘要:
    Microsomal prostaglandin E-2 synthase-1 (mPGES-1) has been recognized as novel, promising drug target for anti-inflammatory and anticancer drugs. mPGES-1 catalyzes the synthesis of the inducible prostaglandin E-2 in response to pro-inflammatory stimuli, rendering this enzyme extremely interesting in drug discovery process owing to the drastic reduction of the severe side effects typical for traditional non-steroidal anti-inflammatory drugs. In the course of our investigations focused on this topic, we identified two interesting molecules bearing the gamma-hydroxybutenolide scaffold which potently inhibit the activity of mPGES-1. Notably, the lead compound 2c that inhibited mPGES-1 with IC50 = 0.9 mu M, did not affect other related enzymes within the arachidonic acid cascade. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.06.032
  • 作为产物:
    参考文献:
    名称:
    Design and synthesis of a second series of triazole-based compounds as potent dual mPGES-1 and 5-lipoxygenase inhibitors
    摘要:
    Microsomal prostaglandin E-2 synthase (mPGES)-1 and 5-lipoxygenase (5-LO) are pivotal enzymes in the biosynthesis of the pro-inflammatory PGE(2) and leukotrienes, respectively. The design and synthesis of a second series of mPGES-1 inhibitors based on a triazole scaffold are described. Our studies allowed us to draw a tentative SAR profile and to optimize this series with the identification of compounds 10, 11 and 14-15 which displayed potent mPGES-1 inhibition in a cell-free assay. In addition, compounds 5, 10, 12 and 14-16 also blocked 5-LO activity in cell-free and cell-based test systems, emerging as very promising candidates for the development of safer and more effective anti-inflammatory drugs. (C) 2012 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2012.05.014
点击查看最新优质反应信息

文献信息

  • One-Pot Palladium-Catalyzed Cross-Coupling Treble of Borylation, the Suzuki Reaction and Amination
    作者:Howard Jong、Stanley T.-C. Eey、Yee Hwee Lim、Sangeeta Pandey、Nurul Azmah Bte Iqbal、Fui Fong Yong、Edward G. Robins、Charles W. Johannes
    DOI:10.1002/adsc.201600708
    日期:2017.2.20
    A methodology for a sequential palladiumcatalyzed crosscoupling procedure consisting of borylation, the Suzuki reaction and amination has been developed for the assembly of molecules with multi‐aryl backbones. The linchpin of this development is the meta‐terarylphosphine ligand, Cy*Phine, which has been employed as an air‐ and moisture‐stable precatalyst, Pd(Cy*Phine)2Cl2, to improve the efficiency
    已经开发了一种由硼化,Suzuki反应和胺化组成的顺序钯催化交叉偶联程序的方法,用于组装具有多芳基骨架的分子。这一发展的关键是间-叔芳基膦配体Cy * Phine,已被用作对空气和湿气稳定的前催化剂Pd(Cy * Phine)2 Cl 2,以提高一锅硼化-铃木反应的效率。此外,可以调整Pd-Cy * Phine系统的反应性,以提供一锅,硼化-铃木反应-胺化(BSA)交叉耦合的三重峰。该方法成功地整合了三个截然不同的模块化反应的互补条件。每个区段的平均产量可达到74-94%,在一个锅中,在整个三步过程中累计提供50-84%的产量。
  • <i>para</i> ‐Selective C−H Borylation of (Hetero)Arenes by Cooperative Iridium/Aluminum Catalysis
    作者:Lichen Yang、Kazuhiko Semba、Yoshiaki Nakao
    DOI:10.1002/anie.201701238
    日期:2017.4.18
    para‐Selective C−H borylation of benzamides and pyridines has been achieved by cooperative iridium/aluminum catalysis. A combination of iridium catalysts commonly employed for arene C−H borylation and bulky aluminum‐based Lewis acid catalysts provides an unprecedented strategy for controlling the regioselectivity of C−H borylation to give variously substituted (hetero)arylboronates, which are versatile
    苯甲酰胺和吡啶的对位C-H硼化已通过铱/铝协同催化实现。芳烃CH硼化中常用的铱催化剂和庞大的铝基路易斯酸催化剂的结合提供了一种空前的策略,可控制CH硼化的区域选择性,从而得到各种取代的(杂)芳基硼酸酯,它们是复杂的多用途合成中间体多取代的芳族化合物。
  • Amide Effects in C−H Activation: Noncovalent Interactions with L-Shaped Ligand for <i>meta</i> Borylation of Aromatic Amides
    作者:Ranjana Bisht、Md Emdadul Hoque、Buddhadeb Chattopadhyay
    DOI:10.1002/anie.201809929
    日期:2018.11.26
    A new concept for the meta‐selective borylation of aromatic amides is described. It has been demonstrated that while esters gave para borylations, amides lead to meta borylations. For achieving high meta selectivity, an L‐shaped bifunctional ligand has been employed and engages in an O⋅⋅⋅K noncovalent interaction with the oxygen atom of the moderately distorted amide carbonyl group. This interaction
    描述了芳族酰胺间选择性硼化的新概念。已经证明,尽管酯产生对硼烷基化,但是酰胺导致间硼烷基化。为了实现较高的间位选择性,使用了L型双功能配体,该配体与中度扭曲的酰胺羰基的氧原子发生O⋅⋅⋅K非共价相互作用。这种相互作用提供了对元CH活化/基化的特殊控制。
  • Development of new highly potent imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1
    作者:Espérance Moine、Isabelle Dimier-Poisson、Cécile Enguehard-Gueiffier、Cédric Logé、Mélanie Pénichon、Nathalie Moiré、Claire Delehouzé、Béatrice Foll-Josselin、Sandrine Ruchaud、Stéphane Bach、Alain Gueiffier、Françoise Debierre-Grockiego、Caroline Denevault-Sabourin
    DOI:10.1016/j.ejmech.2015.10.004
    日期:2015.11
    Using a structure-based design approach, we have developed a new series of imidazo[1,2-b]pyridazines, targeting the calcium-dependent protein kinase-1 (CDPK1) from Toxoplasma gondii. Twenty derivatives were thus synthesized. Structure-activity relationships and docking studies confirmed the binding mode of these inhibitors within the ATP binding pocket of TgCDPK1. Two lead compounds (16a and 16f) were
    使用基于结构的设计方法,我们开发了一系列新的咪唑并[1,2- b ]哒嗪类药物,靶向弓形虫的钙依赖性蛋白激酶-1(CDPK1)。由此合成了二十种衍生物。结构活性关系和对接研究证实了这些抑制剂在Tg CDPK1的ATP结合口袋中的结合模式。然后鉴定了两种先导化合物(16a和16f),它们能够在低纳摩尔浓度下阻断Tg CDPK1的酶促活性,并且对一组哺乳动物激酶具有良好的选择性。这些抑制剂的潜力已在体外T上得到证实。刚地生长,EC 50值分别为100 nM和70 nM。这些最佳候选物还显示出对哺乳动物细胞的低毒性,并被选择用于急性弓形虫病小鼠模型的进一步体内研究。
  • Kinase Scaffold Repurposing for Neglected Disease Drug Discovery: Discovery of an Efficacious, Lapatanib-Derived Lead Compound for Trypanosomiasis
    作者:Gautam Patel、Caitlin E. Karver、Ranjan Behera、Paul J. Guyett、Catherine Sullenberger、Peter Edwards、Norma E. Roncal、Kojo Mensa-Wilmot、Michael P. Pollastri
    DOI:10.1021/jm400349k
    日期:2013.5.23
    Human African trypanosomiasis (HAT) is a neglected tropical disease caused by the protozoan parasite Trypanosoma brucei. Because drugs in use against HAT are toxic and require intravenous dosing, new drugs are needed. Initiating lead discovery campaigns by using chemical scaffolds from drugs approved for other indications can speed up drug discovery for neglected diseases. We demonstrated recently that the 4-anilinoquinazolines lapatinib (GW572016, 1) and canertinib (CI-1033) kill T. brucei with low micromolar EC50 values. We now report promising activity of analogues of 1, which provided an excellent starting point for optimization of the chemotype. Our compound optimization that has led to synthesis of several potent 4-anilinoquinazolines, including NEU617, 23a, a highly potent, orally bioavailable inhibitor of trypanosome replication. At the cellular level, 23a blocks duplication of the kinetoplast and arrests cytokinesis, making it a new chemical tool for studying regulation of the trypanosome cell cycle.
查看更多

同类化合物

(4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (2-肟基-氰基乙酸乙酯)-N,N-二甲基-吗啉基脲六氟磷酸酯 鲸蜡基乙基吗啉氮鎓乙基硫酸盐 马啉乙磺酸钾 预分散OTOS-80 顺式4-(氮杂环丁烷-3-基)-2,2-二甲基吗啉 顺式-N-亚硝基-2,6-二甲基吗啉 顺式-3,5-二甲基吗啉 顺-2,6-二甲基-4-(4-硝基苯基)吗啉 非屈酯 雷奈佐利二聚体 阿瑞杂质9 阿瑞吡坦磷的二卞酯 阿瑞吡坦杂质 阿瑞吡坦杂质 阿瑞吡坦 阿瑞吡坦 阿瑞匹坦非对映异构体2R3R1R 阿瑞匹坦杂质A异构体 阿瑞匹坦杂质54 阿瑞匹坦-M3代谢物 钾[2 - (吗啉- 4 -基)乙氧基]甲基三氟硼酸 邻苯二甲酸单吗啉 调节安 试剂2-(4-Morpholino)ethyl2-bromoisobutyrate 茂硫磷 苯甲腈,2-(4-吗啉基)-5-[1,4,5,6-四氢-4-(羟甲基)-6-羰基-3-哒嗪基]- 苯甲曲秦 苯甲吗啉酮 苯基2-(2-苯基吗啉-4-基)乙基碳酸酯盐酸盐 苯二甲吗啉一氢酒石酸盐 苯二甲吗啉 苯乙酮 O-(吗啉基羰基甲基)肟 芬美曲秦 芬布酯盐酸盐 芬布酯 脾脏酪氨酸激酶(SYK)抑制剂 脱氯利伐沙班 脱氟雷奈佐利 羟基1-(3-氯苯基)-2-[(1,1-二甲基乙基)氨基]-1-丙酮盐酸盐 福沙匹坦苄酯 福沙匹坦杂质26 福曲他明 碘化N-甲基丙基吗啉 碘化N-甲基,乙基吗啉 硝酸吗啉 盐酸吗啡啉-D8 甲基吗啉-2-羧酸甲酯2,2,2-三氟乙酸盐 甲基N-[3-(乙酰基氨基)-4-[(2-氰基-4,6-二硝基苯基)偶氮]苯基]-N-乙基-&#x3B2-丙氨酸酸酯 甲基4-吗啉二硫代甲酸酯